Paul Bessette

Paul Bessette

King & Spalding

Contact
View Bio
RSS

Latest Posts › Biotechnology

Share:

Dismissal of Securities Claims Against Utah Biotech Company Provides Guidance in Securities Cases Involving Food & Drug...

A district court in Utah recently dismissed claims brought against a biotechnology company and its officers under Section 10(b) of the Securities Exchange Act and Rule 10b-5 adopted thereunder. The order in Richfield v....more

4/27/2023  /  Biotechnology , Dismissals , Food and Drug Administration (FDA) , Investigational New Drug Application (IND) , License Applications , Motion to Dismiss , Popular , Securities Exchange Act , State Securities Claims
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide